Your browser doesn't support javascript.
Infection control in the intensive care unit: expert consensus statements for SARS-CoV-2 using a Delphi method.
Nasa, Prashant; Azoulay, Elie; Chakrabarti, Arunaloke; Divatia, Jigeeshu V; Jain, Ravi; Rodrigues, Camilla; Rosenthal, Victor D; Alhazzani, Waleed; Arabi, Yaseen M; Bakker, Jan; Bassetti, Matteo; De Waele, Jan; Dimopoulos, George; Du, Bin; Einav, Sharon; Evans, Laura; Finfer, Simon; Guérin, Claude; Hammond, Naomi E; Jaber, Samir; Kleinpell, Ruth M; Koh, Younsuck; Kollef, Marin; Levy, Mitchell M; Machado, Flavia R; Mancebo, Jordi; Martin-Loeches, Ignacio; Mer, Mervyn; Niederman, Michael S; Pelosi, Paolo; Perner, Anders; Peter, John V; Phua, Jason; Piquilloud, Lise; Pletz, Mathias W; Rhodes, Andrew; Schultz, Marcus J; Singer, Mervyn; Timsit, Jéan-François; Venkatesh, Balasubramanian; Vincent, Jean-Louis; Welte, Tobias; Myatra, Sheila N.
  • Nasa P; NMC Speciality Hospital, Dubai, United Arab Emirates.
  • Azoulay E; Saint-Louis Teaching Hospital, APHP, University of Paris, Paris, France.
  • Chakrabarti A; Postgraduate Institute of Medical Education and Research, Chandigarh, India.
  • Divatia JV; Tata Memorial Hospital, Homi Bhabha National Institute, Mumbai, India.
  • Jain R; Mahatma Gandhi Medical College and Hospital, Jaipur, India.
  • Rodrigues C; PD Hinduja National Hospital and Medical Research Centre, Mumbai, India.
  • Rosenthal VD; International Nosocomial Infection Control Consortium, Miami, FL, USA.
  • Alhazzani W; McMaster University, Hamilton, ON, Canada.
  • Arabi YM; King Saud bin Abdulaziz University for Health Sciences, Riyadh, Saudi Arabia; King Abdullah International Medical Research Center, Riyadh, Saudi Arabia.
  • Bakker J; New York University Grossman School of Medicine, New York, NY, USA; Columbia University Vagelos College of Physicians and Surgeons, New York, NY, USA; Erasmus University Medical Center, Rotterdam, Netherlands; Pontificia Universidad Catolica de Chile, Santiago, Chile.
  • Bassetti M; Department of Health Sciences, University of Genoa, Genoa, Italy.
  • De Waele J; Ghent University Hospital, Ghent, Belgium.
  • Dimopoulos G; Attikon University Hospital, Athens, Greece; National and Kapodistrian University of Athens, School of Medicine, Athens, Greece.
  • Du B; State Key Laboratory of Rare, Complex and Critical Diseases, Peking Union Medical College Hospital, Peking Union Medical College and Chinese Academy of Medical Sciences, Beijing, China.
  • Einav S; Shaare Zedek Medical Center, Jerusalem, Israel; Faculty of Medicine, Hebrew University, Jerusalem, Israel.
  • Evans L; University of Washington, Seattle, WA, USA.
  • Finfer S; The George Institute for Global Health, University of New South Wales, Sydney, NSW, Australia; Imperial College London, London, UK.
  • Guérin C; University de Lyon, Lyon, France; Institut Mondor de Recherches Biomédicales, Créteil, France.
  • Hammond NE; The George Institute for Global Health, University of New South Wales, Sydney, NSW, Australia; Malcolm Fisher Department of Intensive Care, Royal North Shore Hospital, Newton, Adelaide, SA, Australia.
  • Jaber S; Hôpital Saint-Éloi, Montpellier University Hospital, Montpellier, France.
  • Kleinpell RM; Vanderbilt University School of Nursing, Vanderbilt University, Nashville, TN, USA.
  • Koh Y; College of Medicine, University of Ulsan College of Medicine, University of Ulsan, Seoul, South Korea.
  • Kollef M; Washington University School of Medicine, Washington University, St Louis, MO, USA.
  • Levy MM; Warren Alpert Medical School, Brown University, Providence, RI, USA.
  • Machado FR; Hospital Sao Paulo, Universidade Federal de São Paulo, São Paulo, Brazil.
  • Mancebo J; Hospital de Sant Pau, Barcelona, Spain.
  • Martin-Loeches I; St James's Hospital, Dublin, Ireland.
  • Mer M; Charlotte Maxeke Johannesburg Academic Hospital, Johannesburg, South Africa; Faculty of Health Sciences University of the Witwatersrand, Johannesburg, South Africa.
  • Niederman MS; Weill Cornell Medical Center, New York, NY, USA.
  • Pelosi P; IRCCS for Oncology and Neurosciences, San Martino Policlinico Hospital, Genoa, Italy; University of Genoa, Genoa, Italy.
  • Perner A; Rigshospitalet, Copenhagen University Hospital, Copenhagen, Denmark.
  • Peter JV; Christian Medical College, Vellore, India.
  • Phua J; Alexandra Hospital, National University Health System, Singapore; National University Hospital, National University Health System, Singapore.
  • Piquilloud L; University Hospital and University of Lausanne, Lausanne, Switzerland.
  • Pletz MW; Institute of Infectious Diseases and Infection Control, Jena University Hospital, Jena, Germany.
  • Rhodes A; St George's University Hospitals NHS Foundation Trust, London, UK.
  • Schultz MJ; Amsterdam University Medical Centers, Locatie AMC, Amsterdam, Netherlands; Mahidol Oxford Tropical Medicine Research Unit, Mahidol University, Bangkok, Thailand; Nuffield Department of Medicine, University of Oxford, Oxford, UK.
  • Singer M; University College London, London, UK.
  • Timsit JF; APHP, Hôpital Bichat Medical, IAME, University of Paris, Paris, France.
  • Venkatesh B; The Wesley Hospital, Brisbane, QLD, Australia.
  • Vincent JL; Université Libre de Bruxelles, Bruxelles, Belgium.
  • Welte T; German Center of Lung Research, Hannover, Germany.
  • Myatra SN; Department of Anaesthesia, Critical Care and Pain, Tata Memorial Hospital, Homi Bhabha National Institute, Mumbai, India. Electronic address: sheila150@hotmail.com.
Lancet Infect Dis ; 22(3): e74-e87, 2022 03.
Article in English | MEDLINE | ID: covidwho-1510480
ABSTRACT
During the current COVID-19 pandemic, health-care workers and uninfected patients in intensive care units (ICUs) are at risk of being infected with SARS-CoV-2 as a result of transmission from infected patients and health-care workers. In the absence of high-quality evidence on the transmission of SARS-CoV-2, clinical practice of infection control and prevention in ICUs varies widely. Using a Delphi process, international experts in intensive care, infectious diseases, and infection control developed consensus statements on infection control for SARS-CoV-2 in an ICU. Consensus was achieved for 31 (94%) of 33 statements, from which 25 clinical practice statements were issued. These statements include guidance on ICU design and engineering, health-care worker safety, visiting policy, personal protective equipment, patients and procedures, disinfection, and sterilisation. Consensus was not reached on optimal return to work criteria for health-care workers who were infected with SARS-CoV-2 or the acceptable disinfection strategy for heat-sensitive instruments used for airway management of patients with SARS-CoV-2 infection. Well designed studies are needed to assess the effects of these practice statements and address the remaining uncertainties.
Subject(s)

Full text: Available Collection: International databases Database: MEDLINE Main subject: Infection Control / Infectious Disease Transmission, Patient-to-Professional / Consensus / SARS-CoV-2 / COVID-19 / Intensive Care Units Type of study: Clinical Practice Guide Topics: Vaccines Limits: Humans Language: English Journal: Lancet Infect Dis Journal subject: Communicable Diseases Year: 2022 Document Type: Article Affiliation country: S1473-3099(21)00626-5

Similar

MEDLINE

...
LILACS

LIS


Full text: Available Collection: International databases Database: MEDLINE Main subject: Infection Control / Infectious Disease Transmission, Patient-to-Professional / Consensus / SARS-CoV-2 / COVID-19 / Intensive Care Units Type of study: Clinical Practice Guide Topics: Vaccines Limits: Humans Language: English Journal: Lancet Infect Dis Journal subject: Communicable Diseases Year: 2022 Document Type: Article Affiliation country: S1473-3099(21)00626-5